234 Table 9.2 IVF/ICSI Treatment Characteristics between Groups Adenomyosis (n=36) Endometriosis (n=61) Combined (n= 93) Control (n=889) P-value Type of treatment IVF 27 (75%)a 46 (75.4%) a 70 (75.3%) a 177 (19.9%) b <0.00053 ICSI 9 (25%)a 15 (24.6%) a 23 (24.7%) a 712 (80.1%) b Ovarian stimulation product Gonal-F 22 (61.1%) a, b 34 (56.7%) b, c 39 (41.5%) c 710 (85.4%) a <0.0053 Menopur 4 (11.1%) a, b 19 (31.7%)b 34 (36.2%)b 56 (6.7%)a Fostimon 0 a 2 (3.3%) a 5 (5.3%) a 42 (5.1%) a Other 0 1 (1.7%) 0 23 (2.8%) Baseline Endometrial Thickness (mm, Median, IQR) 5.0 (4.0) a. b. 3.0 (1.8) b 3.3 (1.0) 3.0 (2.0) a 0.0002 Maximum Endometrial Thickness (mm, Median, IQR) 10.3 (±1.8) 10.2 (±2.2) 10.3 (±2.05) 10.7 (2.97) 0.7941 Number of viable oocytes (Mean, SD) 8.69 (± 5.32) 9.44 (± 5.08) 7.42(± 4.35) 10.12 (± 5.73) <0.00051 Number of viable embryos (Mean, SD) 4.56 (±3.36) 5.61 (± 3.57) 4.30 (± 2.99) 5.53 (± 3.72) 0.0091 Fertilisation rate (Median, IQR) 0.56 IQR: 0.27 0.64 IQR: 0.32 0.60 IQR: 0.50 0.56 IQR: 0.33 0.2152 Embryos Transferred (N) 1 21 (58.3%) 47 (77%) 64 (70.3%) 570(64.2%) 0.1133 2 15 (41.7%) 14 (23%) 27 (29.7%) 318(35.8%) Embryo quality 1* Super 5 (14.7%) 14 (23.7%) 25 (27.8%) 298 (33.7%) 0.2953 Good 6 (17.6%) 8 (13.6%) 12 (13.3%) 105 (11.9%) Fair 15 (44.1%) 27 (45.8%) 36 (40%) 314 (35.6%) Moderate 7 (20.6%) 10 (16.9%) 16 (17.8%) 133(15.1%) Poor 1 (2.9%) 0 1 (3%) 33 (3.7%) Embryo quality 2* Super 2 (15.4%) 2 (16.7%) 0 34 (10.8%) 0.4593 Good 2 (15.4%) 3 (25%) 5 (20%) 40 (12.7%) Fair 8 (61.5%) 4 (5.3%) 14 (56%) 134 (42.7%) Moderate 1 (7.7%) 3 (25%) 5 (20%) 83 (26.4%) Poor 0 0 1 (4%) 23 (7.3%) 1 = One-Way ANOVA, 2 = Kruskal-Wallis Test, 3 = Chi-square Test. Subscript letters denote significant differences between groups with different letters. For normally distributed variables, values are depicted as Mean, standard deviation (SD) and for abnormally distributed variables as Median, Interquartile range (IQR). * In some patients, 2 embryos are transferred. In those cases, embryo quality 2 indicates the quality of the second embryo according to alpha criteria .
RkJQdWJsaXNoZXIy MTk4NDMw